<GlossaryTerm id="CDR0000800359"><TermName>Ayvakit</TermName><TermPronunciation>(AY-vah-kit)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat adults with advanced systemic mastocytosis or certain types of gastrointestinal stromal tumors. It is also being studied in the treatment of other types of cancer. Ayvakit blocks certain proteins, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called avapritinib.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000801154" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Ayvakit&quot;" language="en" id="_3"/><MediaLink ref="CDR0000801155" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Ayvakit&quot;" language="es" id="_4"/><SpanishTermName>Ayvakit</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para el tratamiento de adultos con mastocitosis sistémica en estadio avanzado o ciertos tipos de tumores de estroma gastrointestinal. También está en estudio para el tratamiento de otros tipos de cáncer. Ayvakit bloquea ciertas proteínas, lo que quizás evite la multiplicación de células cancerosas. Es un tipo de inhibidor de tirosina–cinasas. También se llama avapritinib.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2020-01-13</DateFirstPublished><DateLastModified>2021-06-21</DateLastModified><RelatedInformation><RelatedDrugSummaryRef UseWith="en" href="CDR0000800385" url="/about-cancer/treatment/drugs/avapritinib">Avapritinib</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
